Loading clinical trials...
Loading clinical trials...
Blood Flow Restriction Training for Subacromial Pain: A Pilot Randomized Controlled Trial
The goal of this pilot clinical trial is to learn if blood flow restriction training is safe and feasible in patients with subacromial pain. The main questions the investigators aim to answer are: * What problems do participants with shoulder pain encounter when training with blood flow restriction? * Is it feasible to apply blood flow restriction training as part of a physical therapy intervention? * What are some preliminary effects of blood flow restriction training on the recovery of shoulder function and strength? The investigators will compare active blood flow restriction training to sham (an inactive procedure designed to mimic the active training as closely as possible). Participants will: * Visit the clinic for physical therapy visits and exercise with blood flow restriction training for up to 8 weeks * Visit the clinic for tests before starting the treatment, during the treatment (4 weeks), and after the end of the treatment (8 and 26 weeks).
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
No
University of Florida
Gainesville, Florida, United States
Start Date
May 13, 2025
Primary Completion Date
March 31, 2027
Completion Date
December 31, 2028
Last Updated
July 8, 2025
36
ESTIMATED participants
Active BFRT
DEVICE
Sham BFRT
DEVICE
Strengthening Exercises with BFRT
BEHAVIORAL
Skilled Physical Therapy Care
BEHAVIORAL
Lead Sponsor
University of Florida
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07002944